Applied Therapeutics, Inc. (APLT)
Feb 3, 2026 - APLT was delisted (reason: acquired by Cycle Pharmaceuticals)
0.103
0.00 (0.00%)
Inactive · Last trade price
on Feb 2, 2026
Applied Therapeutics Revenue
Applied Therapeutics had revenue of $1.00M in the quarter ending September 30, 2025, with 719.67% growth. This brings the company's revenue in the last twelve months to $1.00M, down -571.70% year-over-year. In the year 2024, Applied Therapeutics had annual revenue of $455.00K, down -95.45%.
Revenue (ttm)
$1.00M
Revenue Growth
-571.70%
P/S Ratio
14.93
Revenue / Employee
$35,714
Employees
28
Market Cap
15.70M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAPLT News
- 25 days ago - Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics - Business Wire
- 4 weeks ago - Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer - Business Wire
- 4 weeks ago - Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension - GlobeNewsWire
- 2 months ago - Cycle Pharmaceuticals to Acquire Applied Therapeutics - GlobeNewsWire
- 3 months ago - Applied Therapeutics Announces Corporate Updates - GlobeNewsWire
- 3 months ago - Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain - Benzinga
- 3 months ago - Applied Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire